https://www.selleckchem.com/pr....oducts/Glycyrrhizic-
ay improve care and clinical outcomes of COVID-19 patients. Polypharmacy and selected drug classes are associated with increased risk of adverse clinical outcomes among COVID-19 patients. Understanding these relationships can enhance risk stratification and evidence-based decision-making that may improve care and clinical outcomes of COVID-19 patients. In patients with right-sided breast cancer (BC) the liver might be partially irradiated during adjuvant radiotherapy (RT). Thus, we performed a prospective observational study t
Me gusta
Comentario
Compartir
